^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    pamufetinib (TAS-115)

    i
    Other names: TAS-115, TAS 115, TAS115
    Associations
    News

    Trials

    Company:
    Otsuka
    Drug class:
    Multi-tyrosine kinase inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    AB122 Platform Study (NCT04999761)
    Phase 1
    Taiho Pharmaceutical Co., Ltd.
    Recruiting
    Last update posted :
    02/16/2024
    Initiation :
    06/01/2021
    Primary completion :
    05/01/2026
    Completion :
    05/01/2026
    KRAS • NRAS
    |
    KRAS mutation • NRAS mutation • KRAS wild-type • RAS wild-type • NRAS wild-type • KRAS exon 2 mutation
    |
    Avastin (bevacizumab) • Cyramza (ramucirumab) • Lytgobi (futibatinib) • Yutuo (zimberelimab) • Lonsurf (trifluridine/tipiracil) • Jeselhy (pimitespib) • pamufetinib (TAS-115)